Ayan, G. Et Al. 2018. Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies. RHEUMATOLOGY INTERNATIONAL , vol.38, no.4 , 607-622.

Ayan, G., Esatoglu, S. N., Hatemi, G., Ugurlu, S., Seyahi, E., Melikoglu, M., ... Fresko, I.(2018). Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies. RHEUMATOLOGY INTERNATIONAL , vol.38, no.4, 607-622.

Ayan, Gizem Et Al. "Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies," RHEUMATOLOGY INTERNATIONAL , vol.38, no.4, 607-622, 2018

Ayan, Gizem Et Al. "Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies." RHEUMATOLOGY INTERNATIONAL , vol.38, no.4, pp.607-622, 2018

Ayan, G. Et Al. (2018) . "Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies." RHEUMATOLOGY INTERNATIONAL , vol.38, no.4, pp.607-622.

@article{article, author={Gizem Ayan Et Al. }, title={Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies}, journal={RHEUMATOLOGY INTERNATIONAL}, year=2018, pages={607-622} }